At 7 years of age, children exposed to maternal depression during pregnancy or SSRI antidepressants exhibited similar changes in white matter architecture.
The largest GWAS study to date provides evidence that despite a high correlation with MDD, PPD may have unique genetic components.
While some antidepressants may affect the metabolism and efficacy of tamoxifen, many antidepressants can be used safely in this population.
Understanding important differences between men and women in terms of response to antipsychotic medications is essential to improving outcomes and decreasing risk for side effects.
This study provides reassuring data on the use of mirtazapine during pregnancy, demonstrating no association between exposure and risk of major malformations or pregnancy loss.
Lithium use during pregnancy was associated with an increased risk of preterm birth and large for gestational age infants.
A recent review and meta-analysis found that upwards of 20% of women with no history of psychiatric illness experience their first bipolar-spectrum mood episode during the perinatal period.
Announcing a new CWMH study on postpartum depression screening and treatment outcomes at Mass General Brigham.
Women with postpartum psychosis are at risk for recurrent illness, but we have limited data regarding risk factors for recurrence.
Changes in maternal sleep and circadian rhythms during pregnancy are associated with infant sleep problems and maternal depression and anxiety.
